Skip to main content
Molecular Therapy logoLink to Molecular Therapy
. 2022 Dec 28;31(2):600. doi: 10.1016/j.ymthe.2022.12.015

Retraction Notice to: Selective Targeting of Checkpoint Kinase 1 in Tumor Cells with a Novel Potent Oncolytic Adenovirus

Qinglei Gao, Jianfeng Zhou, Xiaoyuan Huang, Gang Chen, Fei Ye, Yunping Lu, Kanyan Li, Liang Zhuang, Mei Huang, Gang Xu, Shxuan Wang, Ding Ma
PMCID: PMC9931592  PMID: 36580917

Main text

(Molecular Therapy 13, 928–937; May 2006)

This article has been retracted at the request of the editor-in-chief. Similarities were reported between images in this article and an article in Clinical Cancer Research (Zhou et al., 2005, Clin. Cancer Res. 11, 8431-8440, https://10.1158/1078-0432.CCR-05-1085). Q.J., J.Z., X.H., G.C., Y.L., K.L., L.Z., and D.M. were all authors of the Clinical Cancer Research paper as well. These concerns were initially reported in a Pubpeer thread (https://pubpeer.com/publications/FF881782FF5AFD316D42E0C0F00766). Image analysis performed by the editorial office confirmed findings of image recycling in Figures 2A and 3B of the Molecular Therapy article. This reuse (and in part misrepresentation) of data without appropriate attribution represents a severe abuse of the scientific publishing system.


Articles from Molecular Therapy are provided here courtesy of The American Society of Gene & Cell Therapy

RESOURCES